Embellence Group

Embellence Group

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Embellence Group - Comps dictate Q2 performance

25 juni 2026

  • We forecast net sales of SEK 191m in Q2'26e
  • DTC could weigh on Q2 EBITA, -7% y-o-y at SEK 24m
  • We reiterate our SEK 36-43 fair value range

We forecast EBITA -6% y-o-y in Q2 on elevated DTC efforts

We expect sequentially tougher comps to lead to a deceleration for Embellence Group. Compared to 3.5% organic growth in Q1, we expect deceleration to flat growth in Q2 for net sales of SEK 191m. By segment, we expect the soft spell in Cole & Son to continue from Q1, following changes to the distributíon setup, and we forecast -6% organic growth for this segment. We also forecast a clear organic decline, -19%, for Artscape, versus the same quarter last year in which it launched a product line with a large customer. On the other hand, we expect Pappelina to continue to perform well after the DTC platform update (+20% org. growth) and its External Manufacturing segment to remain at the net sales level it reached in Q1, suggesting 16% growth. We expect stable gross margins to continue from Q1, and a slightly lower absolute opex level as Q1 contained more costs for trade fairs than is typical in Q2. All in all, we forecast adj. EBITA of SEK 24m, -7% y-o-y, as the group ramps up its DTC efforts.

Shift to DTC weighs on '26e EBITA growth

The transition to DTC is likely to keep weighing on profitability through a higher opex ratio: we forecast a 45% opex ratio for 2026 compared to 44% for 2025 and 42% for 2024. As such, we believe Embellence Group's EBITA growth for '26e could be muted at 1%.

We reiterate our fair value range of SEK 36-43

As we make only minor estimate revisions, we reiterate our fair value range of SEK 36-43. The share is currently trading at 7.5/5.2x EV/EBITA '26e/'28e, compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 11x/6.5x '26e/'28e. We estimate a 11-14% FCF yield '26e-'28e, and a dividend yield of 5-5.7% for the same years.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Svedbergs Group - Logistics drag persists into H2 Svedbergs G.. Analys
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys